Zobrazeno 1 - 10
of 324
pro vyhledávání: '"D, Raccah"'
Autor:
Bruno Guerci, Brigitte Delemer, Cyrielle Caussy, L. Groza, Pierre Gourdy, Olivier Ziegler, Philippe Moulin, Renaud Fay, B. Vergès, D. Raccah, S Picard
Publikováno v:
Médecine des Maladies Métaboliques. 12:62-68
Resume Les agonistes du recepteur au glucagon-like peptide-1 (GLP-1) ont desormais une place importante dans la strategie de traitement du diabete de type 2. Il existe neanmoins des sujets non repondeurs. Nous avons analyse les resultats de deux etud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7817d1c91f60e57d6625cbfbdc9cdd7f
https://doi.org/10.1016/s1957-2557(18)30010-5
https://doi.org/10.1016/s1957-2557(18)30010-5
Autor:
D. Raccah
Publikováno v:
Diabetes & Metabolism. 43:110-124
Aim As type 2 diabetes mellitus progresses, most patients require treatment with basal insulin in combination with another agent to achieve recommended glycaemic targets. The purpose of this systematic review was to examine the evidence supporting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc906ffed27f3a8d0a68247b485e63a
https://doi.org/10.1016/j.diabet.2016.11.007
https://doi.org/10.1016/j.diabet.2016.11.007
Publikováno v:
Diabetic Medicine
Aims To identify simple insulin regimens for people with Type 2 diabetes mellitus that can be accepted and implemented earlier in primary and specialist care, taking into consideration each individual's needs and capabilities. Methods Using randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a78c20aa8ca8d26c67996f6e57b30ab
https://pubmed.ncbi.nlm.nih.gov/28574177
https://pubmed.ncbi.nlm.nih.gov/28574177
Autor:
Sylvie Dejager, Paul Valensi, D. Raccah, C. Petit, L. Monnier, D. Huet, P. Serusclat, Bruno Guerci, Stéphane Quéré, C. Colette
Publikováno v:
Médecine des Maladies Métaboliques. 8:415-422
Resume Objectifs Comparer les profils glycemiques nycthemeraux obtenus par enregistrement continu (CGM) avec vildagliptine versus sitagliptine, ajoutees a la metformine chez des patients diabetiques de type 2 insuffisamment controles (HbA 1c 6,5–8,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5ba10a65ecd2bc13d0b1c70e29be469
https://doi.org/10.1016/s1957-2557(14)70840-5
https://doi.org/10.1016/s1957-2557(14)70840-5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
EMC - Endocrinologie - Nutrition. 10:1-8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4c67395d016b1fed9fb69a6bf14f64b
https://doi.org/10.1016/s1155-1941(13)56365-7
https://doi.org/10.1016/s1155-1941(13)56365-7
Autor:
Didier Gouet, S. Lopez, Sylvia Franc, C. Thivolet, P. Jan, R. Fay, A. Chevremont, Yves Reznik, F. Plat, A.-M. Leguerrier, P. Duvezin-Caubet, D. Raccah, G. Ozenne, Bruno Guerci, C. Collet-Gaudillat
Publikováno v:
Médecine des Maladies Métaboliques. 6:531-538
Resume L’evolution des technologies de suivi et de traitement du diabete de type 1 repose, en particulier, sur la mesure continue du glucose couplee a la perfusion continue d’insuline par pompe. Nous rapportons une etude pilote menee chez des pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::085f613aae9ab267962a8c65c91b68d0
https://doi.org/10.1016/s1957-2557(12)70475-3
https://doi.org/10.1016/s1957-2557(12)70475-3
Publikováno v:
Current Medical Research and Opinion. 26:1647-1656
The prevalence of type 2 diabetes (T2DM) increases with age. Older patients have an increased likelihood for T2DM-related morbidity and mortality. The objective of this review is to provide an overview of the challenges in managing T2DM in the elderl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feda1347d8a48db9c64646c42a89eaba
https://doi.org/10.1185/03007995.2010.485881
https://doi.org/10.1185/03007995.2010.485881
Autor:
D. Raccah
Publikováno v:
Médecine des Maladies Métaboliques. 2:S158-S163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd3c31f10b2d8f254d4db1b0888fc39e
https://doi.org/10.1016/s1957-2557(08)70617-5
https://doi.org/10.1016/s1957-2557(08)70617-5
Publikováno v:
Scopus-Elsevier
Experimental Diabetes Research, Vol 2008 (2008)
Experimental Diabetes Research
Experimental Diabetes Research, Vol 2008 (2008)
Experimental Diabetes Research
The C-peptide of proinsulin is important for the biosynthesis of insulin and has for a long time been considered to be biologically inert. Animal studies have shown that some of the renal effects of the C-peptide may in part be explained by its abili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7cb814411d4baf45ded20f47fa9406
https://doi.org/10.1155/2008/281536
https://doi.org/10.1155/2008/281536